| Feb 18, 2026 |
Feb 23, 2026 |
Lieber Jonathan I
|
CFO |
Sell |
90.0
|
+1,711
|
71.17%
|
✗
|
$4K |
| Feb 18, 2026 |
Feb 20, 2026 |
MACKAY MARTIN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 18, 2026 |
Feb 20, 2026 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 13, 2025 |
May 15, 2025 |
Boudreau Helen M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 13, 2025 |
May 15, 2025 |
Chung Wendy
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 13, 2025 |
May 15, 2025 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 13, 2025 |
May 15, 2025 |
Nash Christine A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 13, 2025 |
May 15, 2025 |
Hopfner Robert Lorne
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 13, 2025 |
May 15, 2025 |
Soteropoulos Paula
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 13, 2025 |
May 15, 2025 |
Liu Hui
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 13, 2025 |
May 15, 2025 |
MACKAY MARTIN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 14, 2025 |
Feb 19, 2025 |
Uden Stephen
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 14, 2025 |
Feb 19, 2025 |
Ryder Steven
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 14, 2025 |
Feb 19, 2025 |
Lieber Jonathan I
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2025 |
Jan 6, 2025 |
MACKAY MARTIN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2025 |
Jan 6, 2025 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2025 |
Jan 6, 2025 |
Hopfner Robert Lorne
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2025 |
Jan 6, 2025 |
Liu Hui
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 15, 2024 |
May 17, 2024 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 15, 2024 |
May 17, 2024 |
Boudreau Helen M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 15, 2024 |
May 17, 2024 |
Liu Hui
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 15, 2024 |
May 17, 2024 |
PARMAR KUSH
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 15, 2024 |
May 17, 2024 |
Soteropoulos Paula
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 15, 2024 |
May 17, 2024 |
Nash Christine A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 15, 2024 |
May 17, 2024 |
Hopfner Robert Lorne
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 15, 2024 |
May 17, 2024 |
Chung Wendy
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 15, 2024 |
Feb 16, 2024 |
Uden Stephen
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 15, 2024 |
Feb 16, 2024 |
MACKAY MARTIN
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 15, 2024 |
Feb 16, 2024 |
Lieber Jonathan I
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 15, 2024 |
Feb 16, 2024 |
Ryder Steven
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2024 |
Jan 4, 2024 |
PARMAR KUSH
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2024 |
Jan 4, 2024 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 17, 2023 |
May 19, 2023 |
PARMAR KUSH
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 17, 2023 |
May 19, 2023 |
Nash Christine A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 17, 2023 |
May 19, 2023 |
Boudreau Helen M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 17, 2023 |
May 19, 2023 |
Hopfner Robert Lorne
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 17, 2023 |
May 19, 2023 |
Soteropoulos Paula
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 17, 2023 |
May 19, 2023 |
Liu Hui
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 17, 2023 |
May 19, 2023 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 17, 2023 |
May 19, 2023 |
Chung Wendy
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2023 |
Mar 16, 2023 |
Lieber Jonathan I
|
Officer |
Buy |
91.3
|
+5,000
|
100.00%
|
✗
|
$26.1K |
| Mar 7, 2023 |
Mar 9, 2023 |
PARMAR KUSH
|
Director |
Sell |
20.0
|
-100,000
|
-2.68%
|
✗
|
$820K |
| Mar 7, 2023 |
Mar 9, 2023 |
5AM Partners V, LLC
|
10% Owner |
Sell |
20.0
|
-100,000
|
-2.68%
|
✗
|
$820K |
| Feb 6, 2023 |
Feb 6, 2023 |
Uden Stephen
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 6, 2023 |
Feb 6, 2023 |
Ryder Steven
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 6, 2023 |
Feb 6, 2023 |
MACKAY MARTIN
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 1, 2023 |
Feb 1, 2023 |
Lieber Jonathan I
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 1, 2023 |
Lieber Jonathan I
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2023 |
Jan 5, 2023 |
Liu Hui
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2023 |
Jan 5, 2023 |
PARMAR KUSH
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2023 |
Jan 5, 2023 |
Chung Wendy
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2023 |
Jan 5, 2023 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 15, 2022 |
Nov 17, 2022 |
VIKING GLOBAL INVESTORS LP
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 1, 2022 |
Aug 3, 2022 |
Chung Wendy
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 3, 2022 |
Chung Wendy
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 3, 2022 |
Jun 7, 2022 |
PARMAR KUSH
|
Director |
Sell |
17.5
|
-150,000
|
-3.87%
|
✗
|
$1.9M |
| Jun 3, 2022 |
Jun 7, 2022 |
5AM Opportunities I, L.P.
|
10% Owner |
Sell |
17.5
|
-150,000
|
-3.87%
|
✗
|
$1.9M |
| May 24, 2022 |
May 26, 2022 |
Liu Hui
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 24, 2022 |
May 26, 2022 |
Soteropoulos Paula
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 24, 2022 |
May 26, 2022 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 24, 2022 |
May 26, 2022 |
Boudreau Helen M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 24, 2022 |
May 26, 2022 |
Hopfner Robert Lorne
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 24, 2022 |
May 26, 2022 |
Nash Christine A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 24, 2022 |
May 26, 2022 |
PARMAR KUSH
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 23, 2022 |
May 25, 2022 |
PARMAR KUSH
|
Director |
Sell |
17.5
|
-100,000
|
-2.51%
|
✗
|
$1.3M |
| May 23, 2022 |
May 25, 2022 |
5AM Opportunities I, L.P.
|
10% Owner |
Sell |
17.5
|
-100,000
|
-2.51%
|
✗
|
$1.3M |
| Apr 4, 2022 |
Apr 6, 2022 |
Nash Christine A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 4, 2022 |
Apr 6, 2022 |
Liu Hui
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 6, 2022 |
Liu Hui
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 6, 2022 |
Nash Christine A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 21, 2022 |
Mar 23, 2022 |
Fryer Jeffrey M
|
Officer |
Buy |
86.3
|
+3,000
|
6.81%
|
✗
|
$24.1K |
| Feb 8, 2022 |
Feb 10, 2022 |
5AM Opportunities I, L.P.
|
10% Owner |
Sell |
17.5
|
-210,000
|
-5.01%
|
✗
|
$2.7M |
| Feb 8, 2022 |
Feb 10, 2022 |
PARMAR KUSH
|
Director |
Sell |
17.5
|
-210,000
|
-5.01%
|
✗
|
$2.7M |
| Feb 7, 2022 |
Feb 9, 2022 |
Fryer Jeffrey M
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 7, 2022 |
Feb 9, 2022 |
Uden Stephen
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 7, 2022 |
Feb 9, 2022 |
MACKAY MARTIN
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 7, 2022 |
Feb 9, 2022 |
Ryder Steven
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 19, 2022 |
Jan 21, 2022 |
Fryer Jeffrey M
|
Officer |
Buy |
83.8
|
+1,400
|
3.28%
|
✗
|
$12.2K |
| Jul 28, 2021 |
Jan 14, 2022 |
Uden Stephen
|
Officer |
Buy |
95.0
|
+719,127
|
100.00%
|
✗
|
$98.5K |
| Jul 28, 2021 |
Jan 12, 2022 |
MACKAY MARTIN
|
CEO |
Buy |
95.0
|
+719,126
|
100.00%
|
✗
|
$103.5K |
| Jul 28, 2021 |
Jan 11, 2022 |
Fryer Jeffrey M
|
Officer |
Buy |
95.0
|
+719,125
|
1089.57%
|
✗
|
$94.1K |
| Jan 3, 2022 |
Jan 5, 2022 |
Hopfner Robert Lorne
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2022 |
Jan 5, 2022 |
HUNT RONALD
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2022 |
Jan 5, 2022 |
PARMAR KUSH
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2022 |
Jan 5, 2022 |
SHANNON TIMOTHY M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2022 |
Jan 5, 2022 |
Soteropoulos Paula
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 28, 2021 |
Aug 4, 2021 |
PARMAR KUSH
|
Director |
Buy |
100.0
|
+4,190,724
|
100.00%
|
✗
|
$8M |
| Aug 2, 2021 |
Aug 4, 2021 |
5AM Opportunities I, L.P.
|
10% Owner |
Buy |
100.0
|
+615,384
|
17.21%
|
✗
|
$8M |
|
Aug 4, 2021 |
5AM Ventures V, L.P.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 28, 2021 |
Aug 4, 2021 |
Hopfner Robert Lorne
|
Director |
Buy |
100.0
|
+2,271,311
|
134.36%
|
✗
|
$7.5M |
| Jul 28, 2021 |
Aug 4, 2021 |
HUNT RONALD
|
Director |
Buy |
100.0
|
+2,301,603
|
100.00%
|
✗
|
$4M |
| Jul 28, 2021 |
Aug 4, 2021 |
SHANNON TIMOTHY M
|
Director |
Buy |
97.5
|
+2,409,712
|
100.00%
|
✗
|
$1000K |
| Aug 2, 2021 |
Aug 4, 2021 |
FMR LLC
|
Other |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 29, 2021 |
Aug 2, 2021 |
VIKING GLOBAL INVESTORS LP
|
10% Owner |
Buy |
100.0
|
+806,000
|
23.78%
|
✗
|
$10.5M |
|
Jul 29, 2021 |
VIKING GLOBAL INVESTORS LP
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 29, 2021 |
5AM Ventures V, L.P.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 29, 2021 |
Soteropoulos Paula
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 29, 2021 |
PARMAR KUSH
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 29, 2021 |
Iancovici Lucian
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 29, 2021 |
Boudreau Helen M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |